Cargando…

Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2)

Drug repurposing for COVID-19 has several potential benefits including shorter development time, reduced costs and regulatory support for faster time to market for treatment that can alleviate the current pandemic. The current study used molecular docking, molecular dynamics and protein-protein inte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Egieyeh, Samuel, Egieyeh, Elizabeth, Malan, Sarel, Christofells, Alan, Fielding, Burtram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793299/ https://www.ncbi.nlm.nih.gov/pubmed/33417604 http://dx.doi.org/10.1371/journal.pone.0245258

Ejemplares similares

Exploration of Scaffolds from Natural Products with Antiplasmodial Activities, Currently Registered Antimalarial Drugs and Public Malarial Screen Data
por: Egieyeh, Samuel, et al.
Publicado: (2016)

Prioritization of anti-malarial hits from nature: chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs
por: Egieyeh, Samuel Ayodele, et al.
Publicado: (2016)

Predictive classifier models built from natural products with antimalarial bioactivity using machine learning approach
por: Egieyeh, Samuel, et al.
Publicado: (2018)

A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2
por: Tsegay, Kaleb B., et al.
Publicado: (2021)

Cheminformatic Characterization of Natural Antimicrobial Products for the Development of New Lead Compounds
por: Oselusi, Samson Olaitan, et al.
Publicado: (2021)

Cheminformatic Profiling and Hit Prioritization of Natural Products with Activities against Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Oselusi, Samson O., et al.
Publicado: (2021)

A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa
por: Dube, Admire, et al.
Publicado: (2021)

Improved and optimized drug repurposing for the SARS-CoV-2 pandemic
por: Cohen, Sarel, et al.
Publicado: (2023)

Drug Repurposing Against Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Through Computational Approach
por: Vaseghi, Golnaz, et al.
Publicado: (2022)

Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface
por: Pirolli, Davide, et al.
Publicado: (2023)

Computational Target-Based Screening of Anti-MRSA Natural Products Reveals Potential Multitarget Mechanisms of Action through Peptidoglycan Synthesis Proteins
por: Oselusi, Samson Olaitan, et al.
Publicado: (2022)

In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
por: Maffucci, Irene, et al.
Publicado: (2020)

Computational search for drug repurposing to identify potential inhibitors against SARS-COV-2 using Molecular Docking, QTAIM and IQA methods in viral Spike protein – Human ACE2 interface
por: Faria, Sergio H.D.M., et al.
Publicado: (2021)

Identification of potential inhibitors of SARS-CoV-2 S protein–ACE2 interaction by in silico drug repurposing
por: Tristán-Flores, Fabiola E, et al.
Publicado: (2021)

A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2)
por: Coghi, Paolo, et al.
Publicado: (2021)

Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface
por: Pirolli, Davide, et al.
Publicado: (2023)

In silico drug repurposing for coronavirus (COVID-19): screening known HCV drugs against the SARS-CoV-2 spike protein bound to angiotensin-converting enzyme 2 (ACE2) (6M0J)
por: Kalamatianos, Konstantinos G.
Publicado: (2022)

Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis
por: Alexpandi, Rajaiah, et al.
Publicado: (2020)

SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study
por: Baby, Krishnaprasad, et al.
Publicado: (2021)

Blocking the interactions between human ACE2 and coronavirus spike glycoprotein by selected drugs: a computational perspective
por: Duru, Chidi Edbert, et al.
Publicado: (2021)

Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods
por: Unni, Sruthi, et al.
Publicado: (2020)

Evaluating pharmacy students’ knowledge and skills in reproductive, maternal, new-born and child health care at a South African university
por: Egieyeh, Elizabeth, et al.
Publicado: (2021)

A peptide array pipeline for the development of Spike-ACE2 interaction inhibitors
por: Chopra, Anand, et al.
Publicado: (2022)

In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy
por: Wei, Tian-zi, et al.
Publicado: (2020)

SPIDR: small-molecule peptide-influenced drug repurposing
por: King, Matthew D., et al.
Publicado: (2018)

In-silico and in-vitro screening of Asiatic acid and Asiaticoside A against Cathepsin S enzyme
por: Ajani, Temitope Akinwumi, et al.
Publicado: (2023)

Repurposing Astragalus Polysaccharide PG2 for Inhibiting ACE2 and SARS-CoV-2 Spike Syncytial Formation and Anti-Inflammatory Effects
por: Lee, Chia-Yin, et al.
Publicado: (2023)

Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19
por: Kumar, Pravindra, et al.
Publicado: (2020)

Development and Implementation of an Integrated Framework for Undergraduate Pharmacy Training in Maternal and Child Health at a South African University
por: Egieyeh, Elizabeth Oyebola, et al.
Publicado: (2021)

Comparative Evaluation of Pharmacy Students’ Knowledge and Skills in Maternal and Child Health: Traditional versus Integrated Curriculum
por: Egieyeh, Elizabeth Oyebola, et al.
Publicado: (2022)

Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction
por: Fu, Wenyu, et al.
Publicado: (2020)

Potential Broad Spectrum Inhibitors of the Coronavirus 3CL(pro): A Virtual Screening and Structure-Based Drug Design Study
por: Berry, Michael, et al.
Publicado: (2015)

Therapeutic development by repurposing drugs targeting SARS-CoV-2 spike protein interactions by simulation studies
por: Jamal, Qazi Mohammad Sajid, et al.
Publicado: (2021)

A review of computational drug repurposing
por: Park, Kyungsoo
Publicado: (2019)

A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2
por: Bhattacharya, Rajarshi, et al.
Publicado: (2021)

Anti-Fungal Drug Anidulafungin Inhibits SARS-CoV-2 Spike-Induced Syncytia Formation by Targeting ACE2-Spike Protein Interaction
por: Ahamad, Shahzaib, et al.
Publicado: (2022)

Predicting the Animal Susceptibility and Therapeutic Drugs to SARS-CoV-2 Based on Spike Glycoprotein Combined With ACE2
por: Shen, Min, et al.
Publicado: (2020)

Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates
por: Alazmi, Meshari, et al.
Publicado: (2020)

Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease
por: Hussien, Mostafa A., et al.
Publicado: (2020)

An insight into the inhibitory mechanism of phytochemicals and FDA-approved drugs on the ACE2–Spike complex of SARS-CoV-2 using computational methods
por: Jani, Vinod, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pl5p827puo7g6li5m1vfso7llk